This invention is directed to compounds, which are PDE9 enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The pres
-
Page/Page column 34
(2013/04/25)
More Articles about downstream products of 7606-30-6